Feng JH - Search Results

1

Coexistence of medullary thyroid carcinoma and gastric carcinoma: A case report and literature review.

Gan XX, Feng JH, Cai WS, Xu B. Gan XX, et al. Among authors: feng jh. Asian J Surg. 2024 Apr;47(4):1829-1830. doi: 10.1016/j.asjsur.2023.12.096. Epub 2023 Dec 29. Asian J Surg. 2024. PMID: 38160156 Free article. Review. No abstract available.

2

The association between serum ferritin with colorectal cancer.

Feng Z, Chen JW, Feng JH, Shen F, Cai WS, Cao J, Xu B. Feng Z, et al. Among authors: feng jh. Int J Clin Exp Med. 2015 Dec 15;8(12):22293-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26885206 Free PMC article.

3

Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition.

Shen F, Cai WS, Feng Z, Chen JW, Feng JH, Liu QC, Fang YP, Li KP, Xiao HQ, Cao J, Xu B. Shen F, et al. Among authors: feng z, feng jh. Oncotarget. 2017 Feb 28;8(9):14479-14486. doi: 10.18632/oncotarget.10407. Oncotarget. 2017. PMID: 27391336 Free PMC article.

4

MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma.

Lai YY, Shen F, Cai WS, Chen JW, Feng JH, Cao J, Xiao HQ, Zhu GH, Xu B. Lai YY, et al. Among authors: feng jh. Tumour Biol. 2016 Oct;37(10):14165-14171. doi: 10.1007/s13277-016-5233-5. Epub 2016 Aug 19. Tumour Biol. 2016. PMID: 27542674

5

MiR-639 promoted cell proliferation and cell cycle in human thyroid cancer by suppressing CDKN1A expression.

Lei ST, Shen F, Chen JW, Feng JH, Cai WS, Shen L, Hu ZW, Xu B. Lei ST, et al. Among authors: feng jh. Biomed Pharmacother. 2016 Dec;84:1834-1840. doi: 10.1016/j.biopha.2016.10.087. Epub 2016 Nov 6. Biomed Pharmacother. 2016. PMID: 27829546

6

The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis.

Feng J, Gan X, Shen F, Cai W, Xu B. Feng J, et al. Int J Surg. 2018 Apr;52:166-170. doi: 10.1016/j.ijsu.2018.02.029. Epub 2018 Feb 23. Int J Surg. 2018. PMID: 29481991 Free article. Review.

7

Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.

Feng J, Shen F, Cai W, Gan X, Deng X, Xu B. Feng J, et al. Endocrine. 2018 Sep;61(3):499-505. doi: 10.1007/s12020-018-1644-y. Epub 2018 Jun 16. Endocrine. 2018. PMID: 29909599

8

Prognostic implications of the BRAF-V600^E mutation in papillary thyroid carcinoma based on a new cut-off age stratification.

Gan X, Shen F, Deng X, Feng J, Lu J, Cai W, Peng L, Zheng W, Wang W, Huang P, Chen Z, Guo M, Xu B. Gan X, et al. Oncol Lett. 2020 Jan;19(1):631-640. doi: 10.3892/ol.2019.11132. Epub 2019 Nov 21. Oncol Lett. 2020. PMID: 31897179 Free PMC article.

9

Targeting of TLE3 by miR-3677 in human breast cancer promotes cell proliferation, migration and invasion.

Peng LN, Deng XY, Gan XX, Zhang JH, Ren GH, Shen F, Feng JH, Cai WS, Xu B. Peng LN, et al. Among authors: feng jh. Oncol Lett. 2020 Feb;19(2):1409-1417. doi: 10.3892/ol.2019.11241. Epub 2019 Dec 23. Oncol Lett. 2020. Retraction in: Oncol Lett. 2024 Dec 09;29(2):94. doi: 10.3892/ol.2024.14840 PMID: 32002031 Free PMC article. Retracted.

10

Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma.

Zhong LK, Gan XX, Deng XY, Shen F, Feng JH, Cai WS, Liu QY, Miao JH, Zheng BX, Xu B. Zhong LK, et al. Among authors: feng jh. Oncol Lett. 2020 Sep;20(3):2302-2310. doi: 10.3892/ol.2020.11781. Epub 2020 Jun 26. Oncol Lett. 2020. PMID: 32782547 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters